High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practice - Archive ouverte HAL Access content directly
Journal Articles Multiple Sclerosis Journal Year : 2020

High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practice

(1) , (2) , (3, 4) , (1, 2) , (5, 6) , (7, 6) , (7, 6) , (7, 6) , (6) , (1, 2) , (7, 8, 9)
1
2
3
4
5
6
7
8
9

Abstract

Background - A recent controlled trial suggested that high-dose biotin supplementation reverses disability progression in patients with progressive multiple sclerosis. Objective - To analyze the impact of high-dose biotin in routine clinical practice on disability progression at 12 months. Methods - Progressive multiple sclerosis patients who started high-dose biotin at Nantes or Rennes Hospital between 3 June 2015 and 15 September 2017 were included in this prospective study. Disability outcome measures, patient-reported outcome measures, relapses, magnetic resonance imaging (MRI) data, and adverse events were collected at baseline, 6, and 12 months. Results - A total of 178 patients were included. At baseline, patients were 52.0 ± 9.4 years old, mean Expanded Disability Status Scale (EDSS) score was 6.1 ± 1.3, mean disease duration was 16.9 ± 9.5 years. At 12 months, 3.8% of the patients had an improved EDSS score. Regarding the other disability scales, scores either remained stable or increased significantly. In total, 47.4% of the patients described stability, 27.6% felt an improvement, and 25% described a worsening. Four patients (2.2%) had a relapse. Of the 74 patients (41.6%) who underwent an MRI, 20 (27.0%) had new T2 lesions, 8 (10.8%) had gadolinium-enhancing lesions. Twenty-five (14%) reported adverse event. Conclusion - In this study, high-dose biotin did not seem to be associated with a clear improvement in disability.
Fichier principal
Vignette du fichier
Couloume et al-2020-High-dose biotin in progressive multiple sclerosis.pdf (1.57 Mo) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-02436685 , version 1 (17-02-2020)

Identifiers

Cite

Laura Couloume, Laetitia Barbin, Emmanuelle Leray, Sandrine Wiertlewski, Emmanuelle Le Page, et al.. High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practice. Multiple Sclerosis Journal, 2020, 26 (14), pp.1898-1906. ⟨10.1177/1352458519894713⟩. ⟨hal-02436685⟩
349 View
441 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More